Position in NVS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,684,113
-$167,980 QoQ
Shares Held
10,746
-11.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#475
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 60%
Shared 0%
None 40%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SILVERCREST ASSET MANAGEMENT GROUP LLC holds $298,590,573 across 11 Drug Manufacturers - General names. NVS ranks #10 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
546,930 | $138,903,812 | |
| 2 | MRK |
Merck & Co., Inc.
|
253,643 | $32,593,125 | |
| 3 | AMGN |
Amgen Inc
|
87,964 | $31,853,523 | |
| 4 | ABBV |
AbbVie Inc.
|
108,246 | $27,239,023 | |
| 5 | AZN |
Astrazeneca PLC
|
134,020 | $25,412,872 | |
| 6 | GSK |
GSK plc
|
313,984 | $16,459,041 | |
| 7 | LLY |
ELI LILLY & Co
|
13,666 | $16,391,411 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
66,843 | $3,851,493 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,684,113 | 10,746 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,852,093 | 12,125 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,795,756 | 13,025 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,479,761 | 11,539 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,383,628 | 11,434 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,301,083 | 11,671 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $987,112 | 10,144 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,102,581 | 9,586 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,090,576 | 10,244 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $1,063,449 | 10,994 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,059,579 | 10,494 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,070,039 | 10,505 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,060,059 | 10,505 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,013,932 | 11,021 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $999,825 | 11,021 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $850,399 | 11,188 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $945,721 | 11,188 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $992,715 | 11,313 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,021,299 | 11,676 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $951,755 | 11,638 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,152,543 | 12,632 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $1,090,553 | 12,758 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,207,476 | 12,787 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,082,478 | 12,448 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $1,084,675 | 12,419 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $995,583 | 12,075 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||